• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Top Recommended Veterinary Products
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Feline model chosen for MU's genome project

June 1, 2005

Jefferson City, Mo. — A cat at the University of Missouri (MU) has been chosen to be the genetic model for all cats in the feline genome project.

Jefferson City, Mo. — A cat at the University of Missouri (MU) has been chosen to be the genetic model for all cats in the feline genome project.

Dr. Kristina Narfstrom, of the University of Missouri, is spearheading a nine-month project to map the genetic structure of the feline.

The cat's blood will be used to map the feline genetic structure, allowing for each gene's function to be studied. The process has begun and is expected to take a minimum of nine months for the first steps in the mapping to take place, says Kristina Narfstrom, DVM, PhD, endowed professor MU's veterinary school.

Narfstrom's title as the Ruth M. Kraeuchi Missouri Professorship of Veterinary Ophthalmology and years of collaborated work with the National Cancer Institute put her at the top of the list when The National Human Genome Research Institute, part of the National Institutes of Health was looking for an outlet for a feline with pure heritage.

Daily News Updates

Advertisement

Narfstrom has been breeding Abyssinian cats for more than 30 years and is currently using the selected cat in her work at the university.

"Many will benefit with the mapping, animals and human medicine," Narfstrom says.

Scientists will be able to determine which gene causes diseases in cats, including blindness and cancer, authorities say.

The goal is to create treatments for such genetic abnormalities.

An improved understanding of virus-mediated diseases that could lead to more effective vaccines is an expected result after the gene mapping is completed.

dvm Newsbreak

"It is very important to complete the genetic mapping is cats," Narfstrom says. "Felines are an excellent model in comparative research. After the mapping is complete, the cat can be used in research more effectively," Narfstrom adds.

Retinitis Pigmentosa (RP) one of the hereditary diseases Narfstrom studies may be caused by a mutation in one of 50 different genes and affects cats and humans. There is currently no cure for the disease that eventually causes blindness. Narfstrom remains hopeful that treatment for the disease will come from the mapping.

Related Content:

MedicalFeline Medicine
FDA approves generic drug for managing allergic dermatitis in cats
FDA approves generic drug for managing allergic dermatitis in cats
Tips and tricks for diagnosing canine osteoarthritis early
Tips and tricks for diagnosing canine osteoarthritis early
Performing surgery on dogs with GDV
Performing surgery on dogs with GDV

Advertisement

Latest News

To refer or to not refer

Advice panel for women interested in the veterinary field

AVMA president set to testify before Congress

New Hawaii-based pet CBD brand launches

View More Latest News
Advertisement